Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00433940 · ClinicalTrials.gov registry record
Immune Suppression Of Infants Treated With Steroids
A clinical trial of Hemangioma, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT00433940 is a study of Hemangioma that has completed, run by Medical College of Wisconsin. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00433940, a study of Hemangioma, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to clarify the degree of immune suppression in infants requiring therapy and to create guidelines for evaluation and prevention of infection in infants on oral steroids for hemangiomas.
Conditions Studied
Interventions
- DRUG Prednisolone
Study Locations (1)
Wisconsin
- Children's Hospital of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-10 |
| Est. Completion | 2010-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00433940
The ClinicalTrials.gov registry entry for NCT00433940 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hemangioma appearing as the primary indexed condition, and to 1 intervention - of which Prednisolone is the first listed.
NCT00433940 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00433940 about?
NCT00433940 is a clinical study titled "Immune Suppression Of Infants Treated With Steroids". The goal of this study is to clarify the degree of immune suppression in infants requiring therapy and to create guidelines for evaluation and prevention of infection in infants on oral steroids for hemangiomas.
What is the current status of trial NCT00433940?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2006-10. Estimated completion is 2010-07.
What conditions does trial NCT00433940 study?
This clinical trial studies the following conditions: Hemangioma.
What interventions are being tested in trial NCT00433940?
The interventions under investigation include: Prednisolone (DRUG).
Who is sponsoring clinical trial NCT00433940?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00433940 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemangioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.